Everyone in a study of 100,000 genomes carries genes that change how their medicines work
The promise of drugs matched to your DNA dates from 2003. It is now measurable at scale, just as the money behind it shrinks.
A study of nearly 100,000 genomes from the NIH’s All of Us program found that every participant carries at least one variant in 16 genes that shape how the body handles medicines, with a median of nine. One in four had been prescribed a drug that interacts with a variant they carry. The team, led from the University of Pittsburgh, also found more than 17,000 previously unrecorded variants. The study is published in Science Translational Medicine.
- genomes studied
- ~100,000
- prescribed a drug their genes affect
- 24.4%
- variants never recorded before
- 17,000+
Figures from today’s news: STAT · UPMC and University of Pittsburgh
How we got here
Filter by lens to see one kind of connection. Every point links to its source.
8 connections
- 2003
On 14 April 2003 the Human Genome Project announced it had finished sequencing the human genome, more than two years ahead of schedule. The project began in October 1990.
Why it matters today
Reading 100,000 whole genomes for one study starts here. What took 13 years then is now routine research data.
Source
- 2007
In August 2007 the FDA added genetic information to the label of warfarin, the first widely used drug to get it. Patients with variants in the CYP2C9 or VKORC1 genes may need lower doses. The FDA did not require the test.
Why it matters today
Two genes deciding how much blood thinner is safe: the same kind of gene–drug link the new study counts across 16 genes.
Source
- 2010
In March 2010 the FDA put its strongest warning on the blood thinner Plavix. People with certain CYP2C19 variants turn too little of it into its active form, raising their risk of heart attack and stroke. About 2% to 14% of people are affected, depending on ancestry.
Why it matters today
Plavix is one of the drugs the new study flags, and the rates differ by ancestry. That is why a diverse sample matters.
Source
- 2015
In January 2015 President Obama proposed $215 million for a Precision Medicine Initiative. Its centrepiece was a study of the DNA and health records of one million American volunteers.
Why it matters today
That million-person study became All of Us, the source of today’s data.
Source
- 2018
All of Us opened national enrolment on 6 May 2018, aiming for a million or more volunteers. Congress authorised $1.5 billion over ten years, and the program set out to recruit groups underrepresented in research.
Why it matters today
Its diversity is what let researchers find variants that earlier, mostly European databases missed.
Source
- 2023
In November 2023 UK Biobank made whole genomes from about 500,000 volunteers available to researchers in some 90 countries. About 88% of its participants are white.
Why it matters today
Britain built the bigger genome library. All of Us built a more varied one, and found variants UK Biobank had not.
Sources
- 2026
All of Us expects about $122 million once its budget is final, 80% below its 2023 peak. It has scaled back recruitment and stopped giving participants their genetic results. Its Cures Act funding ends in fiscal year 2027.
Why it matters today
The data proves its worth at the moment the program that collects it is shrinking.
Source
- Nov 2026
More than 300 medicines already carry gene–drug information on their labels. The senior author, Philip Empey, says the next step is “responsible implementation” of testing in clinics.
Why it matters today
Whether doctors test before they prescribe now depends on clinics, insurers and the program’s funding. Follow the thread.
Sources
The pattern in one line
Genetics keeps showing that one dose does not fit everyone; acting on it always depends on who keeps paying.
Threads in this ripple
The people, places and forces here that also turn up in other ripples.
Sources
Every point on the timeline links to where it comes from. Open a source to see who wrote it and how much weight it carries before you leave.
10 sources · 8 facts · 2 expert view
Level 1 · Facts
A primary or established source that can prove what happened.
- Level 1, FactsSTAT · All of Us study finds thousands of new genetic variants affecting drug responses
- Level 1, FactsUPMC and University of Pittsburgh · Everyone Carries Genes That Affect How Medications Work, Pitt Study Finds
- Level 1, FactsNational Human Genome Research Institute (genome.gov) · Human Genome Project Timeline
- Level 1, FactsThe Daily Record (Maryland) · FDA notes role genetic testing can play in safer use of blood thinner
- Level 1, FactsHealthDay News · Plavix Less Effective in Some Patients
- Level 1, FactsMIT Technology Review · U.S. to Develop DNA Study of One Million People
- Level 1, FactsUC Irvine News · UCI calls for volunteers as NIH’s landmark $1.5 billion precision medicine research effort launches nationwide
- Level 1, FactsSTAT · With latest tranche, U.K. Biobank has genome sequences from 500,000 people available for research
Level 2 · Expert view
Analysis or commentary: it adds perspective, but never proves a fact on its own.